ARCB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ArcBest Corp (ARCB) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive indicators such as insider buying and bullish technical trends, the company's recent financial performance is weak, and there are no strong catalysts or proprietary trading signals supporting an immediate buy decision. Holding off for more clarity on earnings and financial recovery is advisable.
The technical indicators show a bullish trend with MACD above 0 and positively contracting, RSI at 84.7 indicating overbought conditions, and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). However, the stock is near resistance levels (R1: 120.432, current price: 118.58), suggesting limited upside in the short term.
Insider buying has increased significantly by 284.68% over the last month.
Analysts from Citi and Jefferies have raised price targets recently, with Citi setting a target of $122 and Jefferies at $125, both maintaining Buy ratings.
Weak financial performance in Q4 2025, with revenue down 2.89% YoY, net income dropping significantly to -$8.12M, and EPS declining by 129.27%.
No recent news or event-driven catalysts.
RSI indicates overbought conditions, suggesting potential for a short-term pullback.
In Q4 2025, the company reported a revenue decline of 2.89% YoY to $972.69M, a net income loss of -$8.12M (down 127.95% YoY), and an EPS drop of 129.27% to -$0.36. Gross margin also declined slightly by 2.30% YoY to 80.83.
Analyst sentiment is mixed. Recent upgrades include Citi raising the price target to $122 and Jefferies to $125, both with Buy ratings. However, JPMorgan lowered its target to $85 with a Neutral rating, citing macro uncertainties and slow freight demand. Stifel raised its target to $116 with a Buy rating, expecting mixed Q1 earnings.
